EX-FILING FEES 5 d506854dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Solid Biosciences Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities

 

               
Security Type  

Security

Class

Title

 

Fee

Calculation

Rule

 

Amount

Registered

(1)

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

               
Equity   Common Stock $0.001 par value per share   Other   90,000 (2)   $5.51 (3)   $495,900 (3)  

$110.20

per

$1,000,000

  $54.65
               
Equity   Common Stock $0.001 par value per share   Other   45,000 (4)   $5.51 (3)   $247,950 (3)  

$110.20

per

$1,000,000

  $27.33
         
Total Offering Amounts     $743,850     $81.98
         
Total Fee Offsets        
         
Net Fee Due               $81.98
  (1)

In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

  (2)

Consists of shares issuable under a new hire inducement stock option award to be granted on January 9, 2023 to a certain employee of the registrant as an inducement material to entry into employment with the registrant in accordance with Nasdaq Listing Rule 5635(c)(4).

  (3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the registrant’s Common Stock as reported on the Nasdaq Global Select Market on January 3, 2023.

  (4)

Consists of shares issuable under a new hire inducement restricted stock unit award to be granted on January 9, 2023 to a certain employee of the registrant as an inducement material to entry into employment with the registrant in accordance with Nasdaq Listing Rule 5635(c)(4).